Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06547099
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-08-01
Brief Title:
Study to Understand Novel Biomarkers in Researching Dementia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Blood Amyloid Tau and Neurodegeneration Biomarkers and Prediction of Clinical Onset Cognitive Decline and Dementia Diagnosis
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SUNBIRD
Brief Summary:
The purpose of this study is to determine the relationships between amyloid tau and neurodegeneration biomarkers in the blood and the presence of Alzheimers disease AD pathology clinical cognitive decline and diagnosis We aim to understand how well blood-based biomarkers can diagnose and predict Alzheimers disease which will help to further develop and validate blood tests for the disease
Detailed Description:
All participants who are eligible and provide informed consent will complete an initial study visit which includes a research blood collection and cognitive assessments Depending on the results of the cognitive assessments participants will complete follow-up visits annually or biennially for additional cognitive testing research blood collections and potential clinical testing for Alzheimers disease as determined by the participants medical provider
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None